Wissenschaft: Stiftung DHD (Der herzkranke Diabetiker)

Kuratoren und Förderer der Stiftung DHD (Der herzkranke Diabetiker) publizieren regelmäßig Beiträge in Fachzeitschriften. Einen Überblick der wissenschaftlichen Veröffentlichungen liefert das Pubmed-Verzeichnis. Hier kann nach Themen und Autoren recherchiert werden.

https://www.ncbi.nlm.nih.gov/pubmed/

Publikationen mit Beteiligung der Stiftung

Stoyanova D, Stratmann B, Schwandt A, Heise N, Mühldorfer S, Ziegelasch HJ, Zimmermann A, Tschoepe D, Holl RW; DPV Initiative

Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 People from diabetes database. Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13915.
Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK.

DIALOGUE study group. Individualised treatment targets in patients with type-2 diabetes and hypertension. Cardiovasc Diabetol. 2018 Jan 22;17(1):18. doi: 10.1186/s12933-018-0661-8.
Schmieder RE, Gitt AK, Koch C, Bramlage P, Ouarrak T, Tschöpe D.

DIALOGUE study group. Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocr Disord. 2015 May 2;15:23. doi: 10.1186/s12902-015-0020-7.
Gitt AK, Bramlage P, Schneider S, Tschöpe D.

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy. Cardiovasc Diabetol. 2015 Feb 3;14:13. doi: 10.1186/s12933-015-0172-9.
Schnell O, Doerr R, Lodwig V, Weissmann J, Lohmann T.

A 3-year follow-up of the Silent Diabetes Study. Diabetologia. 2014 Dec;57(12):2596-8. doi: 10.1007/s00125-014-3378-6. Epub 2014 Sep 17. No abstract available.
Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.

Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry. Int J Clin Pract. 2013 Oct;67(10):1005-14. doi: 10.1111/ijcp.12179. Epub 2013 Aug 28.
Wasem J, Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D.

DiaRegis Study Group. Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registry. Cardiovasc Diabetol. 2013 Mar 20;12:47. doi: 10.1186/1475-2840-12-47.
Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.

Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry]. Herz. 2012 May;37(3):294-300. doi: 10.1007/s00059-012-3611-3.
Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschöpe D.

Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline. Cardiovasc Diabetol. 2010 Sep 16;9:53. doi: 10.1186/1475-2840-9-53.

Wissenschaft

Publikationen mit Beteiligung der Stiftung

Forschung: